Novel strategies to target lung cancer metastasis to bone
针对肺癌骨转移的新策略
基本信息
- 批准号:10646351
- 负责人:
- 金额:$ 17.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-15 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:A549AdenocarcinomaAdenocarcinoma In SituAllelesAntibodiesBehaviorBreastCalciumCancer Cell GrowthCancer ControlCancer EtiologyCancer PatientCause of DeathCell LineCell SurvivalCellsClinicalComplexConsumptionDataDiagnosisDietDietary InterventionDiseaseDisseminated Malignant NeoplasmElementsEnvironmentEtiologyEventFailureFemoral FracturesFractureFrequenciesGenetically Engineered MouseGrowthHomingHyperplasiaImageImmune systemIncidenceIntakeKRASG12DKnowledgeLinkLoxP-flanked alleleLuciferasesLungLung AdenocarcinomaMalignant NeoplasmsMalignant neoplasm of lungMetastatic Neoplasm to the BoneMethodologyMicroscopyMineralsModalityModelingMonitorMusNeoplasm MetastasisNutritionalOsteoporosisPainPharmaceutical PreparationsPhenotypePhosphotransferasesPhysiologicalPre-Clinical ModelPrevalencePreventionPrevention approachProcessPrognosisProstateRecoveryRegulationResolutionRisk FactorsSerumSiteSkeletonSoilTNFSF11 geneTestingTherapeuticTherapeutic StudiesTransgenic MiceTropismTumor PromotionTumor Suppressor ProteinsXenograft Modelbisphosphonatebonebone imagingbone lossbone metabolismbone turnovercancer cellcancer diagnosiscancer preventioncell behaviorcellular imagingcomorbiditydraining lymph nodedrug repurposingfracture riskhuman migrationimaging modalityin vivoinnovationinorganic phosphateinsightlanthanum carbonatelifestyle factorsmetastatic processmicroCTmouse modelneoplastic cellnovelnovel anticancer drugnovel strategiesnovel therapeutic interventionnutritionosteopontinpain reductionpharmacologicpre-clinicalpreventrelease factorsensorside effectskeletaltherapeutic targetthree dimensional cell culturetumortumor progression
项目摘要
Project Summary/Abstract:
Metastasis is the leading cause of death from cancer. Metastasis to bone represents a particularly poor
prognosis. Unfortunately, the skeleton is one of the most common sites of metastasis for cancers such as
breast, prostate and lung. Further, metastasis to bone results in significant pain, loss of mobility and increased
fractures, among other comorbidities. The underlying mechanisms are incompletely understood and treatment
options are mostly limited to attempting to reduce pain and fracture risk after diagnosis. Therefore, an
enhanced understanding of the underlying etiology and/or a novel strategy to prevent or reduce bone
metastasis would represent a significant advance to a field sorely in need of new options. One major obstacle
to understanding, as well as developing therapeutic options for bone metastases is the paucity of pre-clinical
models that faithfully recapitulate this multi-stage complex process. We have identified a novel genetically
engineered mouse model in which to study lung cancer progression and metastasis to bone. Further, we
believe we have identified a novel risk factor for cancer cell growth and survival as well as a factor that strongly
influences the bone microenvironment in inorganic phosphate (Pi). Studies proposed herein will probe at the
underlying mechanisms of bone metastasis combining a state-of-the-art mouse metastasis model, advanced
microscopy and micro-computed tomography in the context of a novel and highly translational nutrition based
prevention approach. Specifically, we will test the hypothesis that: The KrasG12D; Lkb1fl/fl; Rosa-luciferase
mouse represents a model of spontaneous lung cancer metastasis to bone. Further, that this model can be
used to study therapeutic and prevention modalities as well as provide mechanistic insight into this complex
disease. To test this hypothesis we will: 1) therapeutically target spontaneous metastasis to bone using the
KLLlenti mouse model, and 2) determine if differences in Pi transport drive a bone seeking phenotype. Impact:
Results from the current proposal have the potential to provide new information about the mechanisms by
which a common nutritional element might be manipulated to alter cell behavior related to cancer etiology as
well as a better understanding of the skeletal environment which promotes tumor cell establishment.
项目摘要/摘要:
转移是癌症死亡的主要原因。骨转移代表了一种特别差的情况
预后。不幸的是,骨骼是癌症最常见的转移部位之一,例如
乳房、前列腺和肺。此外,骨转移会导致严重疼痛、活动能力丧失和增加
骨折等合并症。根本机制尚不完全了解,治疗方法也不完全清楚
选择大多局限于诊断后尝试减少疼痛和骨折风险。因此,一个
增强对潜在病因的了解和/或预防或减少骨质疏松的新策略
转移将代表着一个急需新选择的领域的重大进步。一大障碍
缺乏临床前研究是理解骨转移以及开发骨转移治疗方案的关键。
模型忠实地概括了这个多阶段的复杂过程。我们已经鉴定出一种新的基因
工程小鼠模型用于研究肺癌进展和骨转移。此外,我们
相信我们已经发现了癌细胞生长和存活的一个新的危险因素,以及一个强烈影响癌细胞生长和存活的因素。
影响无机磷酸盐(Pi)的骨微环境。本文提出的研究将探讨
结合最先进的小鼠转移模型、先进的骨转移的潜在机制
显微镜和微型计算机断层扫描在一种新颖且高度转化的营养学背景下
预防方法。具体来说,我们将测试以下假设: KrasG12D; Lkb1fl/fl;蔷薇荧光素酶
小鼠代表了自发性肺癌骨转移的模型。此外,该模型可以
用于研究治疗和预防方式,并提供对该复合体的机制洞察
疾病。为了检验这一假设,我们将:1)使用以下方法治疗自发性骨转移:
KLLlenti 小鼠模型,2) 确定 Pi 运输的差异是否驱动寻骨表型。影响:
当前提案的结果有可能通过以下方式提供有关该机制的新信息:
可以操纵一种常见的营养元素来改变与癌症病因学相关的细胞行为,例如
以及更好地了解促进肿瘤细胞建立的骨骼环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE R. BECK其他文献
GEORGE R. BECK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE R. BECK', 18)}}的其他基金
Novel strategies to target lung cancer metastasis to bone
针对肺癌骨转移的新策略
- 批准号:
10513138 - 财政年份:2022
- 资助金额:
$ 17.93万 - 项目类别:
ShEEP Request For A Pre-Clinical In-Vivo X-Ray Micro Computed-Tomography Scanner
ShEEP 请求临床前体内 X 射线微型计算机断层扫描仪
- 批准号:
10178581 - 财政年份:2020
- 资助金额:
$ 17.93万 - 项目类别:
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass
生物活性纳米颗粒和刺激自噬以改善骨量
- 批准号:
8634211 - 财政年份:2014
- 资助金额:
$ 17.93万 - 项目类别:
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass
生物活性纳米颗粒和刺激自噬以改善骨量
- 批准号:
9280823 - 财政年份:2014
- 资助金额:
$ 17.93万 - 项目类别:
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass
生物活性纳米颗粒和刺激自噬以改善骨量
- 批准号:
8634211 - 财政年份:2014
- 资助金额:
$ 17.93万 - 项目类别:
Bio-active Nanoparticles and the stimulation of autophagy for improved bone mass
生物活性纳米颗粒和刺激自噬以改善骨量
- 批准号:
8974367 - 财政年份:2014
- 资助金额:
$ 17.93万 - 项目类别:
Contribution of Phosphate to Inflammatory Bone Loss
磷酸盐对炎性骨质流失的影响
- 批准号:
10588936 - 财政年份:2013
- 资助金额:
$ 17.93万 - 项目类别:
Inorganic phosphate regulated proliferation, transformation and tumorigenesis
无机磷酸盐调节增殖、转化和肿瘤发生
- 批准号:
8240098 - 财政年份:2010
- 资助金额:
$ 17.93万 - 项目类别:
Inorganic phosphate regulated proliferation, transformation and tumorigenesis
无机磷酸盐调节增殖、转化和肿瘤发生
- 批准号:
7889954 - 财政年份:2010
- 资助金额:
$ 17.93万 - 项目类别:
Inorganic phosphate regulated proliferation, transformation and tumorigenesis
无机磷酸盐调节增殖、转化和肿瘤发生
- 批准号:
8076343 - 财政年份:2010
- 资助金额:
$ 17.93万 - 项目类别:
相似国自然基金
基于DNA八面体的DNMT1原位可视化检测与靶向降解技术在三阴性乳腺癌早期预警与干预中的应用
- 批准号:32371473
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于CtSDR的mRNA原位成像新策略及乳腺癌HER2低表达精准诊断应用
- 批准号:82372334
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
端粒酶激活型DNA纳米机器用于环状RNA原位成像及三阴性乳腺癌的转移监测研究
- 批准号:82302348
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
原位前列腺癌中的神经浸润及药物的协同神经治疗研究
- 批准号:82372127
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于乳腺癌类器官的华蟾酥毒基“原位”靶点鉴定及作用机制研究
- 批准号:82304785
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel strategies to target lung cancer metastasis to bone
针对肺癌骨转移的新策略
- 批准号:
10513138 - 财政年份:2022
- 资助金额:
$ 17.93万 - 项目类别:
Role of Telmisartan on Intra-Tumoral Distribution of Targeted Nanoparticles
替米沙坦对靶向纳米颗粒肿瘤内分布的作用
- 批准号:
8791884 - 财政年份:2014
- 资助金额:
$ 17.93万 - 项目类别:
Role of Telmisartan on Intra-Tumoral Distribution of Targeted Nanoparticles
替米沙坦对靶向纳米颗粒肿瘤内分布的作用
- 批准号:
8637758 - 财政年份:2014
- 资助金额:
$ 17.93万 - 项目类别:
Mutagenesis of p53 by reactive PAH and ROS
反应性 PAH 和 ROS 对 p53 的诱变
- 批准号:
8076428 - 财政年份:2010
- 资助金额:
$ 17.93万 - 项目类别:
Expression of Heparan Sulfate 6-O-Endosulfatases in Idiopathic Pulmonary Fibrosis
硫酸乙酰肝素6-O-内切硫酸酯酶在特发性肺纤维化中的表达
- 批准号:
7837606 - 财政年份:2009
- 资助金额:
$ 17.93万 - 项目类别: